1- Umeoka S,
Koyama T,
Miki Y,
Akai M,
Tsutsui K,
Togashi K.
Pictorial Review of Tuberous Sclerosis in Various Organs.
RadioGraphics 2008;28:e32.
2- Crino P.B,
Nathanson K.L and Henske E.P.
The Tuberous Sclerosis Complex.
N Engl J Med 2006;355:1345-56.
3- Napolioni V and Curatolo P.
Genetics and Molecular Biology of Tuberous Sclerosis Complex.
Curr Genomics.
2008;9:475–87.
4- Roach ES,
Gomez MR and Northrup H.
Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria.
J Child Neurol 1998;13:624-8.
5- Anne G.
Osborn.
Oborn's Brain: Imaging,
Pathology,
and Anatomy.
Amirsys.
2012: 1073-1125.
6- McMurdo SK,
Moore SG,
Brant-Zawadzki M,
et al.
MR imaging of intracranial tuberous sclerosis.
AJR Am J Roentgenol 1987;148:791-6.
7- Evans JC,
Curtis J.
The radiological appearances of tuberous sclerosis.
Br J Radiol 2000;73:91-8.
8- Goh S,
Butler W,
Thiele EA.
Subependymal giant cell tumors in tuberous sclerosis complex.
Neurology 2004;63:1457-61.
9- Nir A,
Tajik AJ,
Freeman WK,
et al.
Tuberous sclerosis and cardiac rhabdomyoma.
Am J Cardiol 1995;76:419-21.
10- Pallisa E,
Sanz P,
Roman A,
Majo J,
Andreu J,
Caceres J.
Lymphangioleiomyomatosis: pulmonary and abdominal findings with pathologic correlation.
Radiographics 2002;22(Special Issue):S185-98.
11- Ristagno RL,
Biddinger PW,
Pina EM,
Meyer CA.
Multifocal micronodular pneumocyte hyperplasia in tuberous sclerosis.
AJR Am J Roentgenol 2005;184:S37-9.
12- Keith AC,
L.
F.
Donnelly,
B.
Chen and J.
J.
Bissler.
Tuberous Sclerosis Complex: Renal Imaging Findings.
Radiology 2002;225:451-6.
13- Logue LG,
Acker RE,
Sienko AE.
Best cases from the AFIP: angiomyolipomas in tuberous sclerosis.
Radiographics 2003;23:241-246.
14- Moulis H,
Garsten JJ,
Marano AR,
Elser JM.
Tuberous sclerosis complex: review of the gastrointestinal manifestations and report of an unusual case.
Am J Gastroenterol 1992;87:914-8.
15- Schwartz RA,
Fernández G,
Kotulska K,
and Sergiusz Józwiak S.
Tuberous sclerosis complex: Advances in diagnosis,
genetics,
and management.
Journal of the American Academy of Dermatology (JAAD).
2007;2:189-202.
16- Huson SM,
Compston DA,
Clark P,
Harper PS.
A gnenetic study of von Recklinhausen neurofibromatosis in south east Wales.
Prevalence,
fitness,
mutation rates,
and effect of parenteral transmission on severity.
J Med Genet 1989; 26:704-11.
17- Biondetti PR,
Vigo M,
Flore D,
et al.
CT appearance of generalized von Recklinghausen neurofibromatosis.
Jcomput Assist Tomogr 1983;7:866-9.
18- Xu GF,
O’Connell P,
Viskochil D,
et al.
The neurofibromatosis type I gene encodes a protein related to GAP.
Cell 1990;62:599-608.
19- Fortman BJ,
Kuszyk BS,
Urban BA,
Fishman EK.
Neurofibromatosis type 1: a diagnostic mimicker at CT.
Radiographics 2001; 21: 601-12.
20- Gutmann DH,
Aylsworth A,
Carey JC et al.
The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.
JAMA 1997; 278 :51-7.
21- Van Es S,
North KN,
McHugh K,
De Silva M.
MRI findings in children with neurofibromatosis type 1: a prospective study .
Pediatric Radiology 1996; 26: 478-87.
22- Myong NH,
Lee SS,
Shu YL,
Chi JG.
Optic Nerve Glioma with Neurofibromatosis.
Korean J Pathol.
1993 Oct;27:524-30.
23- Zeid JL,
Charrow J,
Sandu M,
Goldman S,
Listernick R.
Magnetic resonance imaging signs of optic nerve gliomas in neurofibromatosis 1.
American Journal of Ophthalmology.
1991;111:729-34.
24- DeBella K,
Poskitt K,
Szudek J,
Friedman JM.
Use of “unidentified bright objects” on MRI for diagnosis of neurofibromatosis 1 in children.
Neurology.
2000;8:1646-51.
25- Szudek J,
Friedman JM.
Unidentified bright objects associated with features of neurofibromatosis 1.
Pediatric Neurology.
2002;2:123-12.
26- Tonsgard JH,
Kwak SM,
Short MP,
Dachman AH.
CT imaging in adults with neurofibromatosis‐1 frequent asymptomatic plexiform lesion.
Neurology 1998;6:1755-60.
27- Bourgouin PM,
Shepard JO,
Moore EH and McLoud TC.
Plexiform neurofibromatosis of the mediastinum: CT appearance.
AJR.
1988;151: 461-3.
28- Kim H,
Kim HS,
Moon ES,
Yoon CS,
Chung TS,
Song OT et al.
Scoliosis Imaging: What Radiologists Should Know.
RadioGraphics.
2010;30:1823-42.
29- Levy AD,
Remotti HE,
Thompson WM,
Sobin LH,
and Miettinen M.
From the Archives of the AFIP Gastrointestinal Stromal Tumors: Radiologic Features with Pathologic Correlation.
RadioGraphics 2003;23:283–304.
30- Levy AD,
Patel N,
Dow N,
Abbott RM,
Miettinen M and Sobin LH.
Abdominal Neoplasms in Patients with Neurofibromatosis Type 1: Radiologic-Pathologic Correlation.
RadioGraphics.
2005;25:455-80.
31- Rha SE,
Byun JY,
Jung SE,
Chun HJ,
Lee HG,
and Lee JM.
Neurogenic Tumors in the Abdomen: Tumor Types and Imaging Characteristics.
RadioGraphics.
2003;23:29 – 43.
32- Cai W,
Kassarjian A,
Bredella MA,
Harris GJ,
Yoshida H,
Mautner VF,
Wenzel R,
Plotkin SR.
Tumor burden in patients with neurofibromatosis types 1 and 2 and schwannomatosis: determination on whole-body MR images.
Radiology.
2009;250:665-73.
33- Sabol Z,
Kipke-Sabol L,
Miklić P,
Hajnsek-Propadalo S,
Sabol F.
Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas,
vestibular schwannomas): from phenotype to gene.
Lijec Vjesn.
2006;128:309-16.
34- Evans RG.
Neurofibromatosis type 2 (NF2): A clinical and molecular review.
Orphanet Journal of Rare Diseases.
2009;4:16.
35- Aoki S,
Barkovich AJ,
Nishimura A,
Kjos BO,
Machida T,
Cogen P,
Edwards M,
Norman D.
Neurofibromatosis Types 1 and 2: Cranial MR Findings.
Radiology 1989; 172:527-34.
36- Evans DGR,
Baser ME,
O'Reilly B,
Rowe J,
Gleeson M,
Saeed S et all.
Management of the patient and family with Neurofibromatosis 2: A consensus conference statement.
Brit J Neurosurg 2005;19:5-12.
37- Evans DG.
Neurofibromatosis 2.
1998 Oct 14 [updated 2011 Aug 18].
In: Pagon RA,
Adam MP,
Bird TD,
Dolan CR,
Fong CT,
Stephens K,
editors.
GeneReviews™ [Internet].
Seattle (WA): University of Washington,
Seattle; 1993-2013.
Available from http://www.ncbi.nlm.nih.gov/books/NBK1201/
38- Bruce R.
Korf.
The phakomatoses.
Neuroimag Clin N Am.
2004;14:139-48.
39- Dow G,
Biggs N,
Evans G,
Gillespie J,
Ramsden R,
King A.
Spinal tumors in neurofibromatosis type 2.
Is emerging knowledge of genotype predictive of natural history? J Neurosurg Spine.
2005;2:574-9.
40- Goutagny S,
Kalamarides M.
Meningiomas and neurofibromatosis.
J Neurooncol.
2010;99:341-7.
41- Rodriguez D,
Poussaint TY .
Neuroimaging findings in neurofibromatosis type 1 and 2.
Neuroimag Clin N Am.
2004;14:149-70.
42- Latif F,
Tory K,
Gnarra J,
Yao M,
Duh FM,
Orcutt ML et al.
Identification of the von Hippel-Lindau disease tumor suppressor gene.
Science.
1993;5112:1317-20.
43- Lonser RR,
Glenn GM,
McClellan W,
Chew EY,
Libutti SK,
Linehan WM et al.
Von Hippel-Lindau disease.
The Lancet 2003;361:9374,2059–67.
44- Maher ER,
Iselius L,
Yates JR,
Littler M,
Benjamin C,
Harris R et al.
Von Hippel-Lindau disease: a genetic study.
J Med Genet 1991;28:443-7.
45- Richard S,
David P,
Marsot-Dupuch K,
Giraud S,
Béroud C,
Resche F.
Central nervous system hemangioblastomas,
endolymphatic sac tumors,
and von Hippel-Lindau disease.
Neurosurg Rev 2000;23:1–22.
46- Wanebo JE,
Lonser RR,
Glenn GM,
Edward H.
The natural history of hemangioblastomas of the central nervous system in patients with von Hippel Lindau disease.
Oldfield.
Journal of Neurosurgery 2003;98:82-94.
47- Neumann HPH and Zbar B.
Renal cysts,
renal cancer and von Hippel-Lindau disease.
Kidney International 1997;51:16–26.
48- Leung RS,
Biswas SV,
Duncan M,
Rankin S.
Imaging Features of von Hippel–Lindau Disease.
RadioGraphics.
2008;28:1,65-79.
49- Levine E,
Collins DL,
Horton WA and Schimke RN.
CT screening of the abdomen in von Hippel-Lindau disease.
AJR.
1982;139:505-10.
50- Hough DM,
Stephens DH,
Johnson CD and Binkovitz LA.
Pancreatic lesions in von Hippel-Lindau disease: prevalence,
clinical significance,
and CT findings.
AJR.
1994;162:1091-4.
51- Hammel PR,
Vilgrain V,
Terris B,
Penfornis A,
Sauvanet A,
Correas JM et al.
Pancreatic involvement in von Hippel–Lindau disease.
Gastroenterology 2000;119: 1087–95.
52- Libutti SK,
Choyke PL,
Bartlett DL,
Vargas H,
McClellan W,
Lubensky I et al.
Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: Diagnostic and management recommendations.
Surgery.
1998;124:1153–5.
53- Marcos HB,
Libutti SK,
Alexander HR,
Lubensky IA,
Bartlett DL,
McClellan M.W et al.
Neuroendocrine Tumors of the Pancreas in von Hippel–Lindau Disease: Spectrum of Appearances at CT and MR Imaging with Histopathologic Comparison.
Radiology 2002;225:751-8.
54- Taouli B,
Ghouadni M,
Corréas JM,
Hammel P,
Couvelard A,
Richard S et al.
Spectrum of Abdominal Imaging Findings in von Hippel-Lindau Disease.
AJR.
2003;181:1049-54.
55- Choyke PL,
Glenn GM,
McClellan M.W,
Patronas NJ,
Linehan WM,
Thar B.
Von Hippel-Lindau Disease: Genetic,
Clinical,
and Imaging Features.
Radiology.
1995; 194:629-42.
56- Vilanova JC,
Barceló J,
Smirniotopoulos JG,
Pérez-Andrés R,
Villalón M,
Miró J.
Hemangioma from Head to Toe: MR Imagingwith Pathologic Correlation.
RadioGraphics.
2004;24:367-85.
57- Griffiths P.
Sturge-Weber Syndrome Revisited: The Role of Neuroradiology.
Neuropediatrics 1996;27:284-94.
58- Rastogi S,
Lee C,
Salamon N.
Neuroimaging in Pediatric Epilepsy: A Multimodality Approach.
Radio